Pharmacoscintigraphic Investigation NN9924 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Semaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 13 Jun 2017 Results (n=26) presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.